Unity Biotechnology, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -0.38%242.381.5%$875.80m
MRNAModerna, Inc. 3.70%148.130.0%$800.85m
VRTXVertex Pharmaceuticals, Inc. 0.00%281.801.9%$479.85m
GILDGilead Sciences, Inc. -0.50%61.501.0%$473.01m
REGNRegeneron Pharmaceuticals, Inc. -0.72%586.872.6%$468.26m
NVAXNovavax, Inc. 8.81%55.9675.7%$433.62m
ILMNIllumina, Inc. 1.40%186.953.3%$340.58m
SNSSSunesis Pharmaceuticals, Inc. -3.35%3.750.7%$262.14m
BIIBBiogen, Inc. 0.76%205.491.8%$239.88m
BNTXBioNTech SE 3.87%154.870.0%$194.40m
CRSPCRISPR Therapeutics AG 1.79%61.860.6%$162.96m
BMRNBioMarin Pharmaceutical, Inc. 0.40%83.214.2%$116.66m
EXASEXACT Sciences Corp. 1.59%40.0217.7%$92.39m
TECHBio-Techne Corp. -0.21%345.914.5%$89.43m
IOVAIovance Biotherapeutics, Inc. 1.18%11.170.0%$89.14m

Company Profile

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.